Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares climbed 59.1% to $0.6679 after the company reported withdrawal of registration statement.
BioVie Inc. (NASDAQ: BIVI) gained 26.2% to $5.87. BioVie recently announced results from two Phase 2 trials assessing NE3107's potential in Parkinson's Disease (PD) and Alzheimer's Disease (AD).
Bit Brother Limited (NASDAQ: BTB) climbed 23.1% to $0.4680.
Vor Biopharma Inc. (NASDAQ: VOR) climbed 21.4% to $5.22 after the company disclosed initial clinical data from VBP101, its Phase 1/2a multicenter, open-label, first-in-human study of tremtelectogene empogeditemcel or “trem-cel” (formerly VOR33) in patients with acute myeloid leukemia. Vor Bio also priced underwritten offering of 15.3 million shares of common stock at $4.30 per share.
FLJ Group Limited (NASDAQ: FLJ) gained 19.1% to $1.59.
MongoDB, Inc. (NASDAQ: MDB) climbed 18.6% to $171.54 after the company reported better-than-expected sales results. The company also issued Q4 and FY23 EPS and sales guidance above analyst estimates.
Titan Medical Inc. (NASDAQ: TMDI) gained 17.8% to $0.7099. Titan Medical suspended special meeting of shareholders in conjunction with initiation of strategic review process.
Yield10 Bioscience, Inc. (NASDAQ: YTEN) climbed 15.6% to $2.0799. Yield10 Bioscience, last month, posted a Q3 loss of $0.71 per share.
Replimune Group, Inc. (NASDAQ: REPL) rose 15.5% to $21.82 after the company announced it entered into a collaboration angreement with Roche, and also announced initial data from the anti-PD1 failed melanoma cohort of the IGNYTE clinical trial and an RP2/3 program update.
Hillstream BioPharma, Inc. (NASDAQ: HILS) gained 14.2% to $0.4799. Hillstream BioPharma recently announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1.
NEXGEL, Inc. (NASDAQ: NXGL) gained 14.1% to $1.3690. NEXGEL reported share repurchase program of up to $500,000 of the company’s common stock.
Wearable Devices Ltd. (NASDAQ: WLDS) jumped ...
Related tickers: GOSS, NXGL, RXDX, CTRM, HILS, GDS, XFOR, ASO, ANGH, COSM, POAI, DDI, TMPO, BIVI, DUO, DAKT, ALVO, YTEN, INVO, EZPW, BRSH, UNIT, SWBI, SKIL, WLDS, CVNA, VOR, UNFI, FLJ, BRQS, MDB, MMAT, CEA, SLNA, CDMO, RNAZ, MTB, VS, GROM, STT, QRTEB, BTB, IBIO, ZUO, ENSC, KC, LOVE, VGFC, REPL, TMDI, WBEV, WORX, NIU, TROO, MRTX.
Read Full Article
